IP Library Granted Patent US 9,579,341
Granted Patent B2
US 9,579,341 · App. 14/086,548 · Granted Feb 28, 2017

Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,579,341
App. No.
14/086,548
Granted
Feb 28, 2017
Kind
B2
Abstract

The invention provides a composition containing hyaluronic acid (HA) or a pharmaceutically-acceptable salt thereof preserved with a cationic preservative and related methods. In one embodiment, the pharmaceutically-acceptable salt is sodium hyaluronate. In another embodiment, the cationic preservative includes benzalkonium.

Claims (25)

1. A method for preparing a preserved hyaluronic acid composition, the method consisting essentially of:

dissolving a cationic preservative which is poly[oxyethylene(dimethyliminio)ethylene(dimethyliminio)ethylenedichloride] in a first quantity of a solvent;

dissolving a quantity of hyaluronic acid (HA) or physiologically-acceptable salt thereof in a second quantity of the solvent wherein the ratio of the first quantity of solvent to the second quantity of solvent is between 1.8:1 and 2.2:1; and

adding the dissolved HA or physiologically-acceptable salt thereof to the dissolved cationic preservative,

wherein precipitation of the cationic preservative and the HA or physiologically-acceptable salt thereof is substantially prevented by preparing separate HA or physiologically-acceptable salt thereof and separate cationic preservative solutions which are then combined.

2. The method of claim 1 , wherein the physiologically-acceptable salt of HA includes sodium hyaluronate.

3. The method of claim 1 , wherein the HA has a molecular weight between about 500,000 daltons and about 4,000,000 daltons.

4. The method of claim 3 , wherein the molecular weight is between about 1,000,000 daltons and about 2,000,000 daltons.

5. The method of claim 1 , wherein the solvent includes water.

6. The method of claim 5 , wherein the solvent further consists essentially of at least one of the following: glycerin, polyethylene glycol (PEG), and propylene glycol.

7. The method of claim 1 , wherein a ratio of the first quantity of the solvent to the second quantity of the solvent is between about 1.8:1 and about 2.2:1.

8. The method of claim 7 , wherein the ratio is about 2:1.

9. The method of claim 1 , further consisting essentially of:

filtering the combined HA or physiologically-acceptable salt thereof and cationic preservative solution.

10. The method of claim 9 , wherein the HA or physiologically-acceptable salt thereof and cationic preservative solution has a transmittance between about 93% and about 98% at 440 nm before filtration.

11. The method of claim 9 , wherein the combined HA or physiologically-acceptable salt thereof and cationic preservative solution has a transmittance between about 95% and about 100% at 440 nm after filtration.

12. The method of claim 1 , wherein the composition has a concentration of unprecipitated HA between about 0.1% and about 0.5%.

13. A composition prepared according to the method of claim 1 .

14. A method for preparing a preserved hyaluronic acid composition, the method consisting essentially of:

dissolving a cationic preservative which is poly[oxyethylene(dimethyliminio)ethylene(dimethyliminio)ethylenedichloride] in a first quantity of a solvent;

dissolving a quantity of hyaluronic acid (HA) or physiologically-acceptable salt thereof in a second quantity of the solvent wherein the ratio of the first quantity of solvent to the second quantity of solvent is between 1.8:1 and 2.2:1;

dissolving a quantity of an anionic cellulose derivative in a third quantity of the solvent;

adding the dissolved HA or physiologically-acceptable salt thereof to the dissolved cationic preservative; and

adding the dissolved anionic cellulose derivative to at least one of the following: the dissolved HA or physiologically-acceptable salt thereof, the dissolved cationic preservative, and the combined dissolved HA or physiologically-acceptable salt thereof and cationic preservative,

wherein precipitation of the cationic preservative and the HA or physiologically-acceptable salt thereof is substantially prevented by preparing separate HA or physiologically-acceptable salt thereof and separate cationic preservative solutions which are then combined.

Assignments (7)
CHANGE OF NAME Recorded Oct 28, 2024
From: JOHNSON & JOHNSON CONSUMER INC.
To: KENVUE BRANDS LLC
Reel/Frame 069267/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0372 →
CERTIFICATE OF CONVERSION Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0521 →
MERGER Recorded Jan 27, 2022
From: JOHNSON & JOHNSON CONSUMER INC.
To: CHENANGO ZERO LLC
Reel/Frame 059618/0521 →
MERGER Recorded Jan 27, 2022
From: CHENANGO ZERO LLC
To: CHENANGO TWO LLC
Reel/Frame 058888/0133 →
MERGER AND CHANGE OF NAME Recorded Jan 27, 2022
From: CHENANGO TWO LLC; CURRAHEE HOLDING COMPANY INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 058888/0210 →
MERGER AND CHANGE OF NAME Recorded Jul 1, 2015
From: MCNEIL-PPC, INC.; JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 036042/0443 →